Patents by Inventor June R. Eisenman

June R. Eisenman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating cancer by administering an epithelum-derived T-cell factor
    Patent number: 7625553
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: December 1, 2009
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Polynucleotides encoding epithelium-derived T-cell factor and uses thereof
    Patent number: 7192935
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: March 20, 2007
    Assignee: Amgen Inc.
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Antibodies to epithelium-derived T-cell factor
    Patent number: 6184359
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: November 9, 1998
    Date of Patent: February 6, 2001
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Method of treatment with epithelium derived T-cell factor
    Patent number: 5985262
    Abstract: Nucleic acid sequences which encode biologically active EMF, expression vectors which direct the expression of ETF, ETE polypeptides, antibodies which specffically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: November 16, 1999
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Epithelium-derived T-cell factor antibodies
    Patent number: 5892001
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: April 6, 1999
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Method for treating or preventing gastrointestinal disease with epithelium-derived T-cell factor
    Patent number: 5707616
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: January 13, 1998
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch
  • Epithelium-derived T-cell factor
    Patent number: 5574138
    Abstract: Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
    Type: Grant
    Filed: February 22, 1995
    Date of Patent: November 12, 1996
    Assignee: Immunex Corporation
    Inventors: Kenneth H. Grabstein, Dirk M. Anderson, June R. Eisenman, Victor Fung, Charles Rauch